Table 2.
Parameter | MV-KICF1 + 1 mM l-isoleucine | MV-KICF1 without l-isoleucine | SH-KIC20d without l-isoleucine |
---|---|---|---|
Growth rate (h−1) | 0.21 ± 0.01 | 0.03 ± 0.01 | 0.08 ± 0.01 |
KIC (mM) | 46.7 ± 4.1 | 31.8 ± 2.1 | 18.8 ± 0.67 |
By-productsc: | |||
KIV (mM) | 13.3 ± 2.2 | 19.0 ± 4.1 | 2.6 ± 0.3 |
KMV (mM) | 8.8 ± 1.3 | 4.9 ± 0.6 | 8.7 ± 0.1 |
l-leucine (mM) | 3.0 ± 0.2 | 10.3 ± 3.1 | 4.8 ± 0.2 |
Molar product yield (mol KIC per mol glucose) | 0.204 ± 0.018 | 0.143 ± 0.010 | 0.084 ± 0.001 |
Volumetric productivity (mmol KIC l−1 h−1) | 1.41 ± 0.13 | 0.34 ± 0.02 | 0.38 ± 0.02 |
Cultivations were performed in 500 ml baffled shake flasks containing 50 ml CGXII minimal medium with 4% (w/v) glucose. Supplementation of l-isoleucine is indicated.
Mean values and standard deviations from three independent cultivations are shown.
Concentrations of l-valine and l-isoleucine were below 2 mM.
Cultivation of SH-KIC20 supplemented with 1 mM l-isoleucine was not tested.